Phase II Study of Neoadjuvant 1, 3-Bis (2-Chloroethyl)-1-Nitrosourea and Temozolomide for Newly Diagnosed Anaplastic Glioma: A North American Brain Tumor Consortium Trial Academic Article uri icon

Overview

MeSH Major

  • Antineoplastic Agents, Alkylating
  • Antineoplastic Combined Chemotherapy Protocols
  • Brain Neoplasms
  • Carmustine
  • Dacarbazine
  • Glioma

abstract

  • This neoadjuvant strategy was associated with significant myelosuppression and a modest response rate in patients with newly diagnosed AG.

publication date

  • April 15, 2004

Research

keywords

  • Academic Article

Identity

Language

  • eng

Digital Object Identifier (DOI)

  • 10.1002/cncr.20157

PubMed ID

  • 15073861

Additional Document Info

start page

  • 1712

end page

  • 6

volume

  • 100

number

  • 8